nautilus.bio - NAUT Net earnings per share for the last 12 months

Symbol and logo of brand Nautilus Biotechnology, Inc. (NAUT)

Nautilus Biotechnology (NAUT) is driving its development vector through a pursuit of becoming the global benchmark in bio-research via unique engineering. The company's annual net profit per share confirms this trend, where -0.46 serves as the current parameter value. Growth is based on AI platform patents and scientific support, while the monetization of proteomics through licenses ensures long-term business sustainability.

NAUT nautilus.bio Net earnings per share for the last four quarters (07/04/2022 - 11/14/2026)

Nautilus Biotechnology, Inc. - analytical breakdowns and key metrics (NAUT)

- current quotes and average value forecast:
Price Chart Nautilus Biotechnology Inc|NAUT - Price Target Chart
- issuer market value details:
Market Valuation Nautilus Bio|NAUT - Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Nautilus Biotechnology|NAUT - Book Valuation of Business|Market Cap to Net Assets Ratio nautilus.bio|NAUT - Aggregate Asset Value
- debt level and financial liquidity data:
Total Debt to Capital Nautilus Biotechnology|NAUT - Long-Term Debt to Equity|Short-Term Debt to Capital Nautilus Biotechnology Inc|NAUT - Company Total Debt Obligations|Debt to Book Capitalization Ratio Nautilus Bio|NAUT - Long-Term Debt|Company Current Liabilities Nautilus Biotechnology|Quick Ratio nautilus.bio
- earnings and multiples data:
NAUT - Company Net Income|Projected Future Earnings Nautilus Biotechnology|NAUT - Price to Earnings Ratio|Forward P/E Multiple Nautilus Biotechnology Inc|NAUT - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nautilus Bio|NAUT - Operating profit before amortization|Earnings per share for the last twelve months Nautilus Biotechnology|NAUT - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months nautilus.bio|NAUT - Earnings per share growth in current year|Net earnings per share growth forecast for next year Nautilus Biotechnology
- total revenue and sales volume data:
NAUT - Company Total Revenue|Projected Sales Volume Nautilus Biotechnology Inc|NAUT - Price-to-Revenue Multiple|Forward Price-to-Revenue Multiple Nautilus Bio
Fundamental company analysis:NAUT - nautilus.bio
Manufactured products of Nautilus Biotechnology, Inc.

Nautilus Biotechnology (NAUT) investments in high-skilled engineering personnel directly impact operating expenses reflected in earnings. This metric calculates the annual net income per share, excluding the impact of the total issuance volume. By analyzing the 12-month rolling specific income, an investor can discern the real business efficiency without quarterly manipulations. This allows for an objective valuation of the asset. The current talent retention strategy determines the long-term financial stability of the company.

Main competitors

TEM - Earnings per share for the last twelve months|QGEN: Earnings per share for the last twelve months|IONS (Ionis) - Net earnings per share for the last 12 months|Repligen Corp (RGEN) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Avidity|CRISPR (CRSP) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months WGS (GeneDx Holdings Corp.)|RARE (ultragenyx.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) BEAM (Beam Therapeutics)|Sarepta Therapeutics - Earnings per share for the last twelve months|Twist Bio - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters 10x TXG|Intellia Therapeutics (NTLA) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months stoketherapeutics.com (STOK)|Net earnings per share for the last 12 months BLFS|WVE (Wave Life Sciences Ltd) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) MAZE|SION - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) PRME (Prime Medicine, Inc.)|TSHA - Net earnings per share for the last 12 months|uniQure - Net earnings per share (EPS TTM)|Earnings per share for the trailing year MGTX (MeiraGTx Holdings)|Regenxbio (RGNX) - Earnings per share for the last twelve months|Earnings per share for the last 12 months SLDB|Earnings per share for the last twelve months Ocugen, Inc.|Net earnings per one share for the last twelve months pacb.com PACB|Earnings per share for the last twelve months Benitec Biopharma (BNTC)|Earnings per share for the last twelve months DSGN (Design Therapeutics Inc)|Earnings per share for the last twelve months Rocket Pharmaceuticals Inc RCKT|4D Molecular Corp (FDMT) - Net earnings per one share for the last twelve months|Lexeo - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Korro Bio, Inc. (KRRO)|EDIT (Editas Medicine) - Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Silence Therapeutics PLC (SLN)|Earnings per share for the last twelve months ProQR|Earnings per share for the last 12 months CDXS (Codexis Bio)|Net earnings per share (EPS TTM) SGMO|Net earnings per share (EPS TTM) metagenomi.co (MGX)|Precision BioSciences, Inc. - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Generation Bio Co GBIO|BOLD: Net earnings per share for the last 12 months|Exicure, Inc. - Earnings per share for the last four quarters|IMNN: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months PHIO|Earnings per share for the last twelve months Mustang Bio Inc|Earnings per share for the last 12 months RNAZ (TransCode)|Net earnings per share (EPS TTM) BNGO|Net earnings per share (EPS TTM) Applied DNA Corp (APDN)|Earnings per share for the last twelve months bluebird bio, Inc. BLUE|IPA: Earnings per share for the last 12 months|Omega Therapeutics, Inc. - Net earnings per share (EPS TTM)|OMIC - Net earnings per share (EPS TTM)|RGLS (Regulus Therapeutics Inc) - Net earnings per share for the last 12 months|Syros Pharmaceuticals, Inc (SYRS) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months TBIO|TCON (traconpharma.com) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) UBX